Purpose <p>This study examined whether task-based functional MRI (fMRI) can provide metrics of local brain activity and hemodynamics typically derived from resting-state fMRI (rsfMRI).</p> Methods <p>Two publicly open datasets from healthy individuals and brain tumor patients were retrospectively used to compare amplitude of low-frequency fluctuations (ALFF) and global signal metrics, namely, global signal correlation (GSC), global signal cross-correlation (GSXC), and global signal time delay (GSTD) derived from motor and language fMRI with those from a&#xa0;reference rsfMRI scan (rest-1). Factors influencing the correlations between each measurement were examined using a&#xa0;mixed-effects model with post-hoc pairwise comparisons.</p> Results <p>Our study included 50&#xa0;healthy subjects (mean age: 29 ± 3&#xa0;years; 32&#xa0;women) and 38&#xa0;patients (45 ± 14&#xa0;years; 24&#xa0;men). Significant correlations (<i>p</i> &lt; 0.001) were found for all metrics between those derived from motor, language, or a&#xa0;second rest scan (rest-2) against rest-1&#xa0;scans for both healthy subjects and patients. Both fMRI type and motion magnitude affected the measurements of healthy subjects’ GSC (fMRI type: <i>F</i> [2, 69.1] = 15.4, <i>p</i> &lt; 0.001; motion: <i>F</i> [1, 123.1] = 8.5, <i>p</i> = 0.004), GSXC (fMRI type: <i>F</i> [2, 69.5] = 18.9, <i>p</i> &lt; 0.001; motion: <i>F</i> [1, 123.2] = 9.89, <i>p</i> = 0.002), and GSTD (fMRI type: <i>F</i> [2, 58.7] = 9.89, <i>p</i> &lt; 0.001; motion: <i>F</i> [1, 123.2] = 15.26, <i>p</i> &lt; 0.001). FMRI type by motion interaction was significant for ALFF (<i>F</i> [2, 65.9] = 6.13, <i>p</i> = 0.004). The effects were less pronounced and observed only for GSC (<i>F</i> [2, 40.4] = 6.1, <i>p</i> = 0.005) and GSXC (<i>F</i> [2, 41.2] = 6.4, <i>p</i> = 0.004) in the clinical dataset.</p> Conclusion <p>Repurposing existing task-based functional MRI data for evaluating local brain activities and hemodynamics is feasible in the entire brain in healthy and brain tumor subjects.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Leveraging Task FMRI Data to Extract Resting-State Metrics in Brain Tumor and Healthy Populations

  • Shiori Amemiya,
  • Jun Kanzawa,
  • Hidemasa Takao,
  • Osamu Abe

摘要

Purpose

This study examined whether task-based functional MRI (fMRI) can provide metrics of local brain activity and hemodynamics typically derived from resting-state fMRI (rsfMRI).

Methods

Two publicly open datasets from healthy individuals and brain tumor patients were retrospectively used to compare amplitude of low-frequency fluctuations (ALFF) and global signal metrics, namely, global signal correlation (GSC), global signal cross-correlation (GSXC), and global signal time delay (GSTD) derived from motor and language fMRI with those from a reference rsfMRI scan (rest-1). Factors influencing the correlations between each measurement were examined using a mixed-effects model with post-hoc pairwise comparisons.

Results

Our study included 50 healthy subjects (mean age: 29 ± 3 years; 32 women) and 38 patients (45 ± 14 years; 24 men). Significant correlations (p < 0.001) were found for all metrics between those derived from motor, language, or a second rest scan (rest-2) against rest-1 scans for both healthy subjects and patients. Both fMRI type and motion magnitude affected the measurements of healthy subjects’ GSC (fMRI type: F [2, 69.1] = 15.4, p < 0.001; motion: F [1, 123.1] = 8.5, p = 0.004), GSXC (fMRI type: F [2, 69.5] = 18.9, p < 0.001; motion: F [1, 123.2] = 9.89, p = 0.002), and GSTD (fMRI type: F [2, 58.7] = 9.89, p < 0.001; motion: F [1, 123.2] = 15.26, p < 0.001). FMRI type by motion interaction was significant for ALFF (F [2, 65.9] = 6.13, p = 0.004). The effects were less pronounced and observed only for GSC (F [2, 40.4] = 6.1, p = 0.005) and GSXC (F [2, 41.2] = 6.4, p = 0.004) in the clinical dataset.

Conclusion

Repurposing existing task-based functional MRI data for evaluating local brain activities and hemodynamics is feasible in the entire brain in healthy and brain tumor subjects.